Correlation Between Medicofarma Biotech and Comp SA
Can any of the company-specific risk be diversified away by investing in both Medicofarma Biotech and Comp SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicofarma Biotech and Comp SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medicofarma Biotech SA and Comp SA, you can compare the effects of market volatilities on Medicofarma Biotech and Comp SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicofarma Biotech with a short position of Comp SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicofarma Biotech and Comp SA.
Diversification Opportunities for Medicofarma Biotech and Comp SA
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Medicofarma and Comp is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Medicofarma Biotech SA and Comp SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Comp SA and Medicofarma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicofarma Biotech SA are associated (or correlated) with Comp SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Comp SA has no effect on the direction of Medicofarma Biotech i.e., Medicofarma Biotech and Comp SA go up and down completely randomly.
Pair Corralation between Medicofarma Biotech and Comp SA
Assuming the 90 days trading horizon Medicofarma Biotech SA is expected to under-perform the Comp SA. In addition to that, Medicofarma Biotech is 2.72 times more volatile than Comp SA. It trades about -0.03 of its total potential returns per unit of risk. Comp SA is currently generating about 0.14 per unit of volatility. If you would invest 4,490 in Comp SA on September 4, 2024 and sell it today you would earn a total of 8,260 from holding Comp SA or generate 183.96% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 97.8% |
Values | Daily Returns |
Medicofarma Biotech SA vs. Comp SA
Performance |
Timeline |
Medicofarma Biotech |
Comp SA |
Medicofarma Biotech and Comp SA Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Medicofarma Biotech and Comp SA
The main advantage of trading using opposite Medicofarma Biotech and Comp SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicofarma Biotech position performs unexpectedly, Comp SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Comp SA will offset losses from the drop in Comp SA's long position.Medicofarma Biotech vs. Movie Games SA | Medicofarma Biotech vs. Echo Investment SA | Medicofarma Biotech vs. Gaming Factory SA | Medicofarma Biotech vs. Mlk Foods Public |
Comp SA vs. SOFTWARE MANSION SPOLKA | Comp SA vs. Varsav Game Studios | Comp SA vs. Pyramid Games SA | Comp SA vs. UF Games SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |